MRK vs VERA · P/E 33, rev $16.61B vs $2.51B cap
Merck & Company Inc (MRK) versus Vera Therapeutics Inc (VERA) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Vera Therapeutics Inc (VERA) is a biotechnology company listed on NASDAQ.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
VERA does not have a complete income-statement cache yet.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. VERA currently screens at market cap $2.51B.
Not investment advice. Open the MRK and VERA stock pages for the full models.
Not investment advice.